Corvus Pharmaceuticals, Inc. - CRVS

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 15
Latest filed: Nov 05, 2026
Form Count
8-K 6
4 6
SCHEDULE 13G 2
SCHEDULE 13G/A 1

Latest files

Filed Form Report period Accession SEC
Nov 05, 2026 8-K Nov 05, 2026 0001171843-26-007175 View
Aug 07, 2026 SCHEDULE 13G — 0000093751-26-000443 View
Aug 06, 2026 8-K Aug 06, 2026 0001171843-26-005317 View
Jul 22, 2026 8-K Jul 21, 2026 0001104659-26-085790 View
Jun 15, 2026 4 Jun 11, 2026 0001610717-26-000222 View
Jun 15, 2026 4 Jun 11, 2026 0001610717-26-000223 View
Jun 15, 2026 4 Jun 11, 2026 0001610717-26-000221 View
Jun 15, 2026 4 Jun 11, 2026 0001610717-26-000220 View
Jun 15, 2026 4 Jun 11, 2026 0001610717-26-000219 View
Jun 12, 2026 8-K Jun 11, 2026 0001171843-26-004094 View
May 20, 2026 4 May 18, 2026 0001610717-26-000160 View
May 15, 2026 SCHEDULE 13G/A — 0000919574-26-003462 View
May 15, 2026 SCHEDULE 13G — 0000919574-26-003217 View
May 14, 2026 8-K May 14, 2026 0001171843-26-003397 View
May 07, 2026 8-K May 07, 2026 0001171843-26-003154 View